Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen to facilitate methadone detoxification and dose reduction
ISRCTN98180939Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Feb 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in opioid use disorder (OUD) comparing Baclofen plus methadone with Placebo plus methadone (2 arms). Primary endpoint: Reduction in methadone dose. Started Feb 2024; status: completed.
02
Drugs
baclofen
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ISRCTN98180939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98180939.